Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
Ziihera
(zanidatamab-hrii)Orphan drugJazz Pharmaceuticals Ireland Limited
Bispecific HER2-directed Antibody [EPC]
12.1 Mechanism of Action Zanidatamab‑hrii is a bispecific HER2-directed antibody that binds to two extracellular sites on HER2. Binding of zanidatamab...
IMFINZI
(durvalumab)Orphan drugstandardAstraZeneca Pharmaceuticals LP
Programmed Death Ligand-1 Blocker [EPC]
12.1 Mechanism of Action Expression of programmed cell death ligand-1 (PD-L1) can be induced by inflammatory signals (e.g., IFN-gamma) and can be expr...
Matthew Krebs, Dr
The Christie Hospital
Andrea B Apolo, M.D., MD
National Cancer Institute (NCI)
📍 BETHESDA, MD
Andrea B Apolo
National Cancer Institute LAO
📍 Birmingham, Alabama
Hongxia Wang, Doctor
Fudan University
Aung Naing
M.D. Anderson Cancer Center
Camila MV Moniz, Doctor
Oncologist
📍 SAN ANTONIO, TX